PBYI FY 2019 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$272M+8.5% YoY

Gross Profit

$235M86.5% margin

Operating Income

-$76M-27.8% margin

Net Income

-$76M-27.8% margin

EPS (Diluted)

$-2.13

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$22M

Stock-Based Comp.

$57M

Balance Sheet

Total Assets

$235M

Total Liabilities

$217M

Stockholders' Equity

$17M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$272M	$251M	+8.5%
Gross Profit	$235M	$216M	+8.8%
Operating Income	-$76M	-$95M	+20.2%
Net Income	-$76M	-$114M	+33.5%